GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » COGS-to-Revenue

BioDelivery Sciences International (FRA:BD5) COGS-to-Revenue : 0.16 (As of Dec. 2021)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International COGS-to-Revenue?

BioDelivery Sciences International's Cost of Goods Sold for the three months ended in Dec. 2021 was €6.1 Mil. Its Revenue for the three months ended in Dec. 2021 was €38.2 Mil.

BioDelivery Sciences International's COGS to Revenue for the three months ended in Dec. 2021 was 0.16.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BioDelivery Sciences International's Gross Margin % for the three months ended in Dec. 2021 was 84.00%.

BioDelivery Sciences International COGS-to-Revenue Historical Data

The historical data trend for BioDelivery Sciences International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International COGS-to-Revenue Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.28 0.19 0.16 0.14

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.14 0.10 0.15 0.16

BioDelivery Sciences International COGS-to-Revenue Calculation

BioDelivery Sciences International's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=20.685 / 147.532
=0.14

BioDelivery Sciences International's COGS to Revenue for the quarter that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=6.109 / 38.191
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioDelivery Sciences International  (FRA:BD5) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BioDelivery Sciences International's Gross Margin % for the three months ended in Dec. 2021 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 6.109 / 38.191
=84.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

BioDelivery Sciences International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (FRA:BD5) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » COGS-to-Revenue
Comparable Companies
SIGA VYGR BYSI PRTA ANIK RUBY DVAX BCEL IMRA XENE OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY
Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
Website
http://www.bdsi.com
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines